A daily dose of aspirin will be prescribed to people living with chronic liver disease in a bid to lower their chances of developing a common and ...

It is a leading cause of liver cancer, responsible for 50%–80% of hepatocellular carcinoma cases globally. 1 Chronic HBV infection leads to the integration of HBV DNA into the host genome ...

It is a leading cause of liver cancer, responsible for 50%-80% of hepatocellular carcinoma cases globally. 1 Chronic HBV infection leads to the integration of HBV DNA into the host genome, resulting ...

Currently, blood-based screening is mostly appropriate for high-risk groups, such as: Prostate cancer: Men over 50 may ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

Gastrointestinal cancers often develop silently but knowing risk factors and warning signs can lead to earlier detection and ...

U.S. medical centers have appealed to the FDA for compassionate use approval of the adenosine receptor inhibitor namodenoson for pancreatic cancer, according to Can-Fite BioPharma. About 85% of ...